U. Specks

511 total citations
9 papers, 322 citations indexed

About

U. Specks is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, U. Specks has authored 9 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 4 papers in Physiology and 3 papers in Surgery. Recurrent topics in U. Specks's work include Vasculitis and related conditions (7 papers), Sarcoidosis and Beryllium Toxicity Research (4 papers) and Eosinophilic Esophagitis (3 papers). U. Specks is often cited by papers focused on Vasculitis and related conditions (7 papers), Sarcoidosis and Beryllium Toxicity Research (4 papers) and Eosinophilic Esophagitis (3 papers). U. Specks collaborates with scholars based in United States, Sweden and Canada. U. Specks's co-authors include Richard A. DeRemee, Rokea A. el‐Azhary, Mazen S. Daoud, Udaya B. S. Prakash, Thomas V. Colby, Lawrence E. Gibson, W. P. Daniel Su, Eric S. Edell, Cees G. M. Kallenberg and Pieter C. Limburg and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Annals of the Rheumatic Diseases and Journal of the American Academy of Dermatology.

In The Last Decade

U. Specks

8 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
U. Specks United States	5	282	142	91	78	73	9	322
Jan Henrik Schirmer Germany	9	210 0.7×	90 0.6×	97 1.1×	53 0.7×	31 0.4×	22	293
Fernando Martínez United States	2	453 1.6×	137 1.0×	41 0.5×	18 0.2×	41 0.6×	3	480
B. Brihaye France	7	143 0.5×	57 0.4×	169 1.9×	87 1.1×	18 0.2×	14	269
Elena Treppo Italy	10	107 0.4×	39 0.3×	80 0.9×	45 0.6×	25 0.3×	28	205
Roció Redondo‐Rodríguez Spain	11	118 0.4×	98 0.7×	105 1.2×	13 0.2×	42 0.6×	23	255
Priyanka Doctor United States	12	111 0.4×	75 0.5×	124 1.4×	17 0.2×	62 0.8×	15	461
Marcos Martinez Del Pero United Kingdom	13	239 0.8×	122 0.9×	148 1.6×	56 0.7×	41 0.6×	23	346
Vincent Grobost France	10	91 0.3×	96 0.7×	71 0.8×	27 0.3×	17 0.2×	20	245
Julie Magnant France	8	95 0.3×	47 0.3×	53 0.6×	21 0.3×	40 0.5×	18	206
C. Agard France	7	185 0.7×	38 0.3×	103 1.1×	29 0.4×	95 1.3×	12	344

Countries citing papers authored by U. Specks

Since Specialization

Citations

This map shows the geographic impact of U. Specks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Specks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Specks more than expected).

Fields of papers citing papers by U. Specks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Specks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Specks. The network helps show where U. Specks may publish in the future.

Co-authorship network of co-authors of U. Specks

This figure shows the co-authorship network connecting the top 25 collaborators of U. Specks. A scholar is included among the top collaborators of U. Specks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. Specks. U. Specks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Specks, U., et al.. (2025). Interstitial lung disease, antineutrophil cystoplasmic antibodies and microscopic polyangiitis. Lara D. Veeken. 64(Supplement_1). i42–i47. 3 indexed citations

Bourdin, Arnaud, et al.. (2024). EFFICACY OF BENRALIZUMAB AND MEPOLIZUMAB ON ASTHMA OUTCOMES IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS. Annals of Allergy Asthma & Immunology. 133(6). S49–S50. 1 indexed citations

Pagnoux, Christian, et al.. (2024). POS0858 HOW SYMPTOMS AND TREATMENTS IMPACT THE EXPERIENCES OF PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS PARTICIPATING IN A CLINICAL TRIAL. Annals of the Rheumatic Diseases. 83. 1071–1072.

Baek, Seung Han, Paneez Khoury, Enrico Maiorino, et al.. (2023). A Transcriptomic Signature of Mepolizumab Response in Eosinophilic Granulomatosis With Polyangiitis (EGPA). A1318–A1318. 1 indexed citations

Limburg, Pieter C., et al.. (2000). Recombinant proteinase 3 produced in different expression systems: recognition by anti-PR3 antibodies. Journal of Immunological Methods. 244(1-2). 117–131. 22 indexed citations

Specks, U., et al.. (1995). Tracheobronchial Involvement in Wegener's Granulomatosis. American Journal of Respiratory and Critical Care Medicine. 151(2). 522–526. 148 indexed citations

Daoud, Mazen S., Lawrence E. Gibson, Richard A. DeRemee, et al.. (1994). Cutaneous Wegener's granulomatosis: Clinical, histopathologic, and immunopathologic features of thirty patients. Journal of the American Academy of Dermatology. 31(4). 605–612. 123 indexed citations

DeRemee, Richard A., et al.. (1994). Lesions of the Respiratory Tract Associated With the Finding of Anti-Neutrophil Cytoplasmic Autoantibodies With a Perinuclear Staining Pattern. Mayo Clinic Proceedings. 69(9). 819–824. 14 indexed citations

Specks, U., Henry A. Homburger, & Richard A. DeRemee. (1993). Implications of c-ANCA Testing for the Classification of Wegener’s Granulomatosis: Performance of Different Detection Systems. Advances in experimental medicine and biology. 336. 65–70. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact